$19.51
-32.19-62.26%
At Close: -
$20.01
0.52.56%
After Hours: Sep 20, 7:58 PM EDT
15 minutes delayed
Corbus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Corbus Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.90 | $-1.26 | 28.6 % |
Mar 2024 | 2024-05-07 | $-0.83 | $-1.52 | 45.4 % |
Dec 2023 | 2024-03-12 | $-1.81 | $-2.36 | 23.3 % |
Sep 2023 | 2023-11-07 | $-2.27 | $-2.06 | -10.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2022 | 2022-08-09 | $0 | $100.00K | -100.0 % |
Mar 2022 | 2022-05-10 | $0 | $150.00K | -100.0 % |
Dec 2021 | 2022-03-08 | $0 | $350.00K | -100.0 % |
Sep 2021 | 2021-11-12 | $97.32K | $650.00K | -85.0 % |
Corbus Pharmaceuticals (CRBP) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.90, which beat the estimate of $-1.26.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.